In both pediatric and adult patients, cranial radiation therapy causes a debilitating cognitive decline that is poorly understood and currently untreatable. This decline is characterized by ...

The FDA approved obecabtagene autoleucel (obe-cel; Aucatzyl) for treating relapsed or refractory B-cell precursor acute ...

During early development the precursors to all these more specialized stem cells, sometimes called "pluripotential stem cells" (PSCs), are found in the inner cell mass of the preimplantation ...

The investigators added that inflammation and demyelination were reduced, while axonal density oligodendrocytes, ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

People who have received transplants for blood cancer, some more than 40 years ago, do not have high rates of potentially ...

FDA approves Autolus Therapeutics' Aucatzyl for adults with relapsed or refractory B-cell precursor acute lymphoblastic ...

A team of international researchers has developed a new method for doping silver (Ag) in solar cells aimed at suppressing ...

The treatment, called Aucatzyl, has been granted marketing approval for the treatment of adult patients with relapsed or refractory B-cell precursor ALL, the London biopharmaceutical company said ...

Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T ...

We have demonstrated that cranial irradiation markedly alters hippocampal progenitor-cell biology. Within the irradiated hippocampus, precursor proliferation is reduced by 62% and neuro-genesis is ...